PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,991,991 | -30.8% | 660,690 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $12,996,000 | +22.9% | 660,690 | +100.6% | 0.00% | +50.0% |
| Q3 2021 | $10,572,000 | -5.2% | 329,343 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $11,148,000 | -9.9% | 329,343 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $12,370,000 | +13.1% | 329,343 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $10,941,000 | +15.0% | 329,343 | +27.0% | 0.00% | 0.0% |
| Q3 2020 | $9,510,000 | +11.4% | 259,343 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $8,535,000 | +27.5% | 259,343 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,696,000 | -32.2% | 259,343 | -18.3% | 0.00% | -33.3% |
| Q4 2019 | $9,881,000 | – | 317,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 7,464,572 | $76,885,092 | 22.93% |
| Propel Bio Management, LLC | 869,927 | $8,960,248 | 5.81% |
| Catalys Pacific, LLC | 721,962 | $7,436,208 | 5.61% |
| Checkpoint Capital L.P. | 875,000 | $9,012,500 | 5.43% |
| Frazier Life Sciences Management, L.P. | 10,109,279 | $104,125,574 | 4.87% |
| Carlyle Group Inc. | 3,496,808 | $35,842,282 | 3.40% |
| Decheng Capital LLC | 850,000 | $8,755,000 | 2.68% |
| Saturn V Capital Management LP | 593,306 | $6,111,052 | 2.31% |
| ORACLE INVESTMENT MANAGEMENT INC | 225,000 | $2,317,500 | 2.16% |
| Ghost Tree Capital, LLC | 600,000 | $6,180,000 | 1.94% |